Drug costs chief concern of Medicare recipients November 03, 2016By Christine BlankMedicare Part D recipients are most concerned about prescription drug costs—and their co-pay costs are the most important factor when choosing a pharmacy. Medicare drug spending spike shows need for generics September 10, 2016By Christine BlankAn exclusive Associated Press report found that Medicare’s spending on certain drugs soared by 85% in two years. Coming regs expand pharmacist role in LTC August 10, 2016By Howard Larkin“Basically, everything we know will be gutted over the next three years.” Patient care at med sync improves outcomes, revenue August 10, 2016By Howard LarkinAnd Medicare, Medicaid, and private insurers are increasingly willing to pay. Health information technology in the community pharmacyLocal HIE, regional EHR, interoperability all over the place -- get your pharmacy ready. They're practically here. Medicare drug costs should parallel those of MedicaidMedicare should have the same authority that Medicaid has to negotiate drug prices directly with manufacturers. If the government can do it for one program, it can do it for another. Provider status June 08, 2016By Fred GebhartWith provider status now a reality in 38 states, HR 592 and S 314 have powerful Congressional support. How long before the payers come on board? The biosimilar balance: More options, lower costsThe fly in the ointment: CMS' current plan for HCPCS codes is a real buzz kill. How pharmacists can find jobs, get paid, and win provider status April 06, 2016By Ronald G. CameronIf nothing changes between now and 2018, we may see a 25% oversupply of pharmacists in the marketplace. Then again, we may not. What happens between now and then is, in large measure, up to us.